Detalles de la búsqueda
1.
Ixekizumab versus FAEs and methotrexate in treatment of nail psoriasis in patients with moderate-to-severe psoriasis.
J Dtsch Dermatol Ges
; 22(2): 278-281, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38185772
2.
Association of disease duration and PASI response rates at week 12 in patients with moderate-to-severe plaque psoriasis receiving biologics in the real-world psoriasis study of health outcomes (PSoHO).
J Dermatolog Treat
; 35(1): 2350227, 2024 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-38797734
3.
Network meta-analyses comparing the efficacy of biologic treatments for achieving complete resolution of nail psoriasis at 24-28 and 48-52 weeks.
J Dermatolog Treat
; 34(1): 2263108, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37781881
Resultados
1 -
3
de 3
1
Próxima >
>>